Lipitor composition history is indicated as an adjunct to diet for reduction of elevated total cholesterol total-CTei norvasc 10 farmacia mg pret LDL-Capolipoprotein B, and triglycerides in lipitor composition history, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia heterozygous variant or combined mixed hyperlipidaemia Corresponding to Types IIa and IIb of the Fredrickson classification when response to diet and other nonpharmacological measures is inadequate.
Treats what symptoms is also indicated to reduce lipitor composition history and LDL-C in lipitor composition history with homozygous familial hypercholesterolaemia as an adjunct to other lipid-lowering lipitor composition history e.
LDL apheresis or if such lipitor composition history are unavailable. Prevention of cardiovascular events in adult patients estimated to have a high risk for a first cardiovascular event see section 5.
The patient lipitor composition history be placed on a standard cholesterol-lowering diet before receiving Lipitor and should continue on this diet during treatment with Lipitor.
Lipitor composition history dose should be individualised according to baseline LDL-C levels, the goal of therapy, and patient response. The usual starting dose lipitor composition history 10 mg once a day. Adjustment of dose should be made at intervals /lasix-patient-education-keto.html 4 weeks or more. The maximum dose is 80 mg once a day.
The majority of patients are controlled with Lipitor 10 mg once a day. A therapeutic response is evident within lipitor composition history weeks, and the lipitor composition history therapeutic response is usually achieved within 4 weeks. The response is maintained during chronic therapy.
Patients should be started with History 10 mg lipitor composition history. Doses should be lipitor composition and history every 4 history to 40 mg daily. Thereafter, either the dose may be increased to a maximum of 80 mg daily or a bile acid sequestrant may be combined with 40 mg atorvastatin once daily. The dose of atorvastatin in patients with homozygous familial hypercholesterolemia is 10 to 80 mg daily see section 5.
Atorvastatin should be used as an adjunct to other lipitor composition history treatments e. LDL apheresis in these patients or if such treatments are unavailable.
Higher doses may be necessary in order to attain LDL- cholesterol levels according to current guidelines. Lipitor should be used with caution in patients with lipitor composition impairment see sections 4.
Lipitor is contraindicated in patients with active liver disease see section 4. Efficacy and safety history patients older than 70 using recommended history composition lipitor composition are similar lipitor composition history those seen in the general population.
Paediatric use should only be carried out by physicians experienced in the treatment of paediatric hyperlipidaemia and patients should be re-evaluated on a regular basis to assess progress.
For patients with Heterozygous Familial Hypercholesterolemia aged 10 years and above, lipitor composition history recommended starting dose of atorvastatin is 10 mg per day see section 5.
The dose may be increased lipitor composition history 80 mg daily, according to the response and tolerability. lipitor composition history
Doses should be individualised according to lipitor composition history recommended lipitor composition history of therapy. Adjustments should be made at intervals of lipitor composition history weeks or more.
The dose titration to 80 mg daily is supported by study data in adults and by limited clinical data from studies in children with Heterozygous Familial Hypercholesterolemia see sections 4.
2018 ©